✦ LIBER ✦

Etoposide (VP-16) scheduling in small cell lung cancer (SCLC), laboratory rationale and clinical results

✍ Scribed by Falk, S.J.; Smith, P.J.; Osborne, R.J.; Bleehen, N.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide (VP-16) and carboplatin as a f

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Carboplatin (CBDOA) plus etoposide (VP16

✍ Crinò, L.; De Marinis, F.; Clerici, M.; Meacci, M.; Cocconi, G.; Malacarne, P.; 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Dose escalation study of carboplatin (CB

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 162 KB

VP-16 and cisplatin (P) in the treatment

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Etoposide (VP-16) and cisplatin in previ

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Etoposide (VP-16) and cytosine arabinosi

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 162 KB